Zhiyi Zhang

A formyl peptide receptor agonist suppresses inflammation and bone damage in arthritis

E. Morand, J. Quinn, H. Fan, 2014, British journal of pharmacology.

Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study.

C. Bao, Huji Xu, Xiangpei Li, 2019, Clinical and experimental rheumatology.